Identification of Potent and Novel α4β1 Antagonists Using in Silico Screening
Identification of Potent and Novel α4β1 Antagonists Using in Silico Screening
复制标题
在硅片筛选中鉴定有效的新型 α4β1 拮抗剂
DOI:
10.1021/jm020054e
复制
发表时间:
2002
影响因子:
7.3
通讯作者:
Steven P. Adams
中科院分区:
文献类型:
--
作者:
Juswinder Singh;Herman van Vlijmen;Yusheng Liao;Wen;M. Cornebise;M. Harris;I;A. Gill;Julio H. Cuervo;William M. Abraham;Steven P. Adams
The antigen α4β1 (very late antigen-4, VLA-4) plays an important role in the migration of white blood cells to sites of inflammation. It has been implicated in the pathology of a variety of diseases including asthma, multiple sclerosis, and rheumatoid arthritis. We describe a series of potent inhibitors of α4β1 that were discovered using computational screening for replacements of the peptide region of an existing tetrapeptide-based α4β1 inhibitor (1; 4-[N‘-(2-methylphenyl)ureido]phenylacetyl-Leu-Asp-Val) derived from fibronectin. The search query was constructed using a model of 1 that was based upon the X-ray conformation of the related integrin-binding region of vascular cell adhesion molecule-1 (VCAM-1). The 3D search query consisted of the N-terminal cap and the carboxyl side chain of 1 because, upon the basis of existing structure−activity data on this series, these were known to be critical for high-affinity binding to α4β1. The computational screen identified 12 reagents from a virtual library of ...